| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/24/2003 | WO2003105826A2 "soluble stable pharmaceutical composition for the administration of hiv protease inhibitors and a process for the preparation of concentrated pharmaceutical compositions for the administration of hiv protease inhibitors." |
| 12/24/2003 | WO2003105823A1 Use of hydroxyeicosatetraenoic acid compounds to treat dry mouth |
| 12/24/2003 | WO2003105813A1 Liner for sticking plaster |
| 12/24/2003 | WO2003105812A1 Gastroretentive drug delivery system comprising an extruded hydratable polymer |
| 12/24/2003 | WO2003105811A2 Controlled release compositions and methods for using same |
| 12/24/2003 | WO2003105810A1 Pharmaceutical compositions for drugs having ph-dependentsolubility |
| 12/24/2003 | WO2003105808A1 Abuse-protected administration form |
| 12/24/2003 | WO2003105807A1 Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations |
| 12/24/2003 | WO2003105805A1 Composition for treatment of inflammatory disorders |
| 12/24/2003 | WO2003105804A1 Ibuprofen suspension |
| 12/24/2003 | WO2003105803A1 Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle |
| 12/24/2003 | WO2003105802A1 Method for fabricating three dimensional sturctures |
| 12/24/2003 | WO2003105800A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/24/2003 | WO2003105781A2 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | WO2003105780A2 A dry powder oligonucleotide formulation, preparation and its uses |
| 12/24/2003 | WO2003105775A2 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 12/24/2003 | WO2003105767A2 Antifungal parenteral products |
| 12/24/2003 | WO2003105765A2 Phospholipid micelles in liposomes as solubilizers for water-insoluble compounds |
| 12/24/2003 | WO2003105731A1 Bone growth compositions and methods |
| 12/24/2003 | WO2003105724A2 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/24/2003 | WO2003105664A2 Optical sampling interface system for in vivo measurement of tissue |
| 12/24/2003 | WO2003105661A2 Materials with both bioadhesive and biodegradable components |
| 12/24/2003 | WO2003105607A1 Nano-sized self-assembled structured liquids |
| 12/24/2003 | WO2003105606A1 Stable emulsions of oils in aqueous solutions and methods for producing same |
| 12/24/2003 | WO2003105585A1 Cosmetic appliance and method of use |
| 12/24/2003 | WO2003096975A3 Pharmaceutical compositions and methods of using c-21 modified epothilone derivatives |
| 12/24/2003 | WO2003090662A3 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease |
| 12/24/2003 | WO2003089568A3 Method of inhibiting restenosis |
| 12/24/2003 | WO2003088765A3 Functional foods containing a phospholipid-containing stable matrix |
| 12/24/2003 | WO2003084519A3 Aerosol formulation for inhalation comprising a tiotropium salt |
| 12/24/2003 | WO2003082340B1 Injectable veterinary composition for small animals |
| 12/24/2003 | WO2003082248A3 Taste masked compositions of erythromycin a and derivatives thereof |
| 12/24/2003 | WO2003079962A3 Assembled unit consisting of individually separable transdermal therapeutic systems |
| 12/24/2003 | WO2003077972A3 Implantable drug delivery system |
| 12/24/2003 | WO2003074370A3 Improved liquid foaming soap compositions and dispensing system therefor |
| 12/24/2003 | WO2003074025A3 Pressurised metered dose inhalers containing solutions of beta-2 agonists |
| 12/24/2003 | WO2003072741A3 Therapeutic regulation of deoxyribonuclease-1-like-3 activity |
| 12/24/2003 | WO2003070153A3 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives |
| 12/24/2003 | WO2003066806A3 Therapeutic use of aziridino compounds |
| 12/24/2003 | WO2003063831A3 Immediate release dosage forms containing solid drug dispersions |
| 12/24/2003 | WO2003063826A3 Ophthalmic compositions including oil-in-water emulsions, and methods for making and using the same |
| 12/24/2003 | WO2003055917A3 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 12/24/2003 | WO2003051394A3 Calcium phosphate particles as mucosal adjuvants |
| 12/24/2003 | WO2003051299A3 Sulfhydryl rifamycins and uses thereof |
| 12/24/2003 | WO2003037296A3 Methods and dosage forms for improving the bioavailability of therapeutic agents |
| 12/24/2003 | WO2003035137A3 Method and apparatus for dispensing inhalator medicament |
| 12/24/2003 | WO2003035046A3 Salts formed of an at1-receptor antagonist and a cardiovascular agent |
| 12/24/2003 | WO2003028701A3 Liposomes containing (ether)lysolecithins |
| 12/24/2003 | WO2003024503A3 Device and method for accurate delivery of an active agent |
| 12/24/2003 | WO2003022239A3 Stable water in oil aminophylline emulsions |
| 12/24/2003 | WO2003007914A3 Biocompatible polymer containing composition for treatment of prostate cancers |
| 12/24/2003 | WO2003000235A9 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 12/24/2003 | WO2002102825A3 Fluorescently labelled locked nucleic acids |
| 12/24/2003 | WO2002068676A3 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 12/24/2003 | WO2002068562A8 Functionalized cubic liquid crystalline phase materials and methods for their preparation and use |
| 12/24/2003 | WO2002068561A8 Cubic liquid crystalline phase precursor |
| 12/24/2003 | WO2002054996A3 Terazosin transdermal device and methods |
| 12/24/2003 | CN2593806Y Suppository packing medicine feeder |
| 12/24/2003 | CN1463191A Low hygroscopic aripiprazole drug substance and processes for prepn. thereof |
| 12/24/2003 | CN1463177A Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds |
| 12/24/2003 | CN1462635A Microzyme vaccine and bacterin for SARS epidemical tissue and its manufacturing method |
| 12/24/2003 | CN1462631A Medicine combination containing white atractylodes rhizome and its preparation method |
| 12/24/2003 | CN1462628A Pasting medicated plaster for treating bone disease |
| 12/24/2003 | CN1462618A Fibrauretine in dosage form of decentralization tablet |
| 12/24/2003 | CN1462617A Alkaloid oral applied drop pills possessing anticarcinogenesis and its preparation method |
| 12/24/2003 | CN1462616A Method of preparing medical use injection containing high oxygen |
| 12/24/2003 | CN1131711C Method of mfg. porous matrix-type controlled release system using emulsion tech |
| 12/24/2003 | CA2779633A1 Combination of azelastine and steroids |
| 12/24/2003 | CA2779630A1 Combination of azelastine and steroids |
| 12/24/2003 | CA2491846A1 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof |
| 12/24/2003 | CA2489854A1 Antifungal medicinal compositions |
| 12/24/2003 | CA2489632A1 Stabilized liquid anti-rsv antibody formulations |
| 12/24/2003 | CA2489534A1 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations |
| 12/24/2003 | CA2489391A1 Stable emulsions of oils in aqueous solutions and methods for producing same |
| 12/24/2003 | CA2489315A1 Formulation of nefopam and its use in the treatment of pain |
| 12/24/2003 | CA2489306A1 Use of nefopam for the treatment of nausea or emesis |
| 12/24/2003 | CA2489250A1 Composition comprising viscous fibers and viscosity-lowering proteins |
| 12/24/2003 | CA2489106A1 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/24/2003 | CA2488879A1 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
| 12/24/2003 | CA2488872A1 Antifungal parenteral products |
| 12/24/2003 | CA2488845A1 Opthalmic compositions containing selective m1 muscarinic agonists for treating ocular hypertension |
| 12/24/2003 | CA2488802A1 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | CA2488782A1 Vaccine comprising mixtures of multivalent meningococcal outer membrane vesciles |
| 12/24/2003 | CA2488752A1 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/24/2003 | CA2488705A1 A nanoporous particle with a retained target |
| 12/24/2003 | CA2488701A1 Reversed liquid crystalline phases with non-paraffin hydrophobes |
| 12/24/2003 | CA2488643A1 Coated particles, methods of making and using |
| 12/24/2003 | CA2488501A1 Nano-sized self-assembled structured liquids |
| 12/24/2003 | CA2488111A1 Beverages containing plant sterols |
| 12/24/2003 | CA2488026A1 Powdery respiratory tonic composition |
| 12/24/2003 | CA2487514A1 Materials with both bioadhesive and biodegradable components |
| 12/23/2003 | US6668196 Ambulatory medical apparatus with hand held communication device |
| 12/23/2003 | US6667393 Azalide antibiotic compositions |
| 12/23/2003 | US6667371 Having hydrophilic and hydrophobic blocks; encapsulation or solubilization of water insoluble materials; sustained release encapsulation |
| 12/23/2003 | US6667344 Formoterol, or a derivative; long term storage stability |
| 12/23/2003 | US6667324 Dry blend pharmaceutical formulations |
| 12/23/2003 | US6667323 Dry-blend pharmaceutical formulations |
| 12/23/2003 | US6667321 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 12/23/2003 | US6667295 DNA vaccine against feline immunodeficiency virus |
| 12/23/2003 | US6667294 Freeze drying aqueous solution |